Mirja Thomsen,Fabian Ott,Sebastian Loens,Gamze Kilic-Berkmen,Ai Huey Tan,Shen-Yang Lim,Ebba Lohmann,Kaja M. Schröder,Lea Ipsen,Lena A. Nothacker,Linn Welzel,Alexandra S. Rudnik,Frauke Hinrichs,Thorsten Odorfer,Kirsten E. Zeuner,Friederike Schumann,Andrea A. Kühn,Simone Zittel,Marius Moeller,Robert Pfister,Christoph Kamm,Anthony E. Lang,Yi Wen Tay,Marie Vidailhet,Emmanuel Roze,Joel S. Perlmutter,Jeanne S. Feuerstein,Victor S. C. Fung,Florence Chang,Richard L. Barbano,Steven Bellows,Aparna A. Wagle Shukla,Alberto J. Espay,Mark S. LeDoux,Brian D. Berman,Stephen Reich,Andres Deik,Andre Franke,Michael Wittig,Sören Franzenburg,Jens Volkmann,Norbert Brüggemann,H. A. Jinnah,Tobias Bäumer,Christine Klein,Hauke Busch,Katja Lohmann

Abstract:Dystonia is one of the most prevalent movement disorders, characterized by significant clinical and etiological heterogeneity. Despite considerable heritability (∼25%) and the identification of several disease-linked genes, the etiology in most patients remains elusive. Moreover, understanding the correlations between clinical manifestation and genetic variants has become increasingly complex. To comprehensively unravel dystonia’s genetic spectrum, we performed exome sequencing on 1,924 dystonia patients [40.3% male, 92.9% White, 93.2% isolated dystonia, median age at onset (AAO) 33 years], including 1,895 index patients, who were previously genetically unsolved. The sample was mainly based on two dystonia registries (DysTract and the Dystonia Coalition). Further, 72 additional patients of Asian ethnicity, mainly from Malaysia, were also included. We prioritized patients with negative genetic prescreening, early AAO, positive family history, and multisite involvement of dystonia. Rare variants in genes previously linked to dystonia ( =405) were examined. Variants were confirmed via Sanger sequencing, and segregation analysis was performed when possible. We identified 137 distinct likely pathogenic or pathogenic variants (according to ACMG criteria) across 51 genes in 163/1,924 patients [42.9% male, 85.9% White, 68.7% isolated dystonia, median AAO 19 years]. This included 153/1,895 index patients, resulting in a diagnostic yield of 8.1%. Notably, 77/137 (56.2%) of these variants were novel, with recurrent variants in , , , and , and novel variant types such as two splice site variants in , supported by functional evidence. Additionally, 321 index patients (16.9%) harbored variants of uncertain significance in 102 genes. The most frequently implicated genes included , , , , , and Presumably pathogenic variants in less well-established dystonia genes were also found, including , , and At least six variants (in , , , , and ) occurred supporting pathogenicity. ROC curve analysis indicated that AAO and the presence of generalized dystonia were the strongest predictors of a genetic diagnosis, with diagnostic yields of 28.6% in patients with generalized dystonia and 20.4% in those with AAO < 30 years. This study provides a comprehensive examination of the genetic landscape of dystonia, revealing valuable insights into the frequency of dystonia-linked genes and their associated phenotypes. It underscores the utility of exome sequencing in establishing diagnoses within this heterogeneous condition. Despite prescreening, presumably pathogenic variants were identified in almost 10% of patients. Our findings reaffirm several dystonia candidate genes and expand the phenotypic spectrum of some of these genes to include prominent, sometimes isolated dystonia.

Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing

Large‐Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes

Dissecting genetic architecture of rare dystonia: genetic, molecular and clinical insights

Genetic spectrum and clinical features in a cohort of Chinese patients with isolated dystonia.

Recent Advances in the Genetics of Dystonia

Clinical and genetic profile of patients with dystonia: An experience from a tertiary neurology center from India

Genetic analysis of dystonia-related genes in Parkinson's disease

Whole-exome Sequencing in a Cohort of Chinese Patients with Isolated Cervical Dystonia

Genetic Update and Treatment for Dystonia

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Clinical and Molecular Genetic Evaluation of Patients with Primary Dystonia

Genetic Dystonias: Update on Classification and New Genetic Discoveries

Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities

Association Between Dystonia-Related Genetic Loci and Parkinson's Disease in Eastern China

Research Progress and Diagnostic Strategy of Genetic Pathogenesis of Dystonia

Dystonia genes and their biological pathways

Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.

Genome-wide Survival Study Identifies a Novel Synaptic Locus and Polygenic Score for Cognitive Progression in Parkinson’s Disease

The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis

Embracing Monogenic Parkinson's Disease: the MJFF Global Genetic PD Cohort.